Sequential senolytic priming followed by systemic recombinant α-Klotho ectodomain administration restores mitochondri...

IF systemic recombinant α-Klotho ectodomain (soluble KL1 domain, 0.01 mg/kg IV, three times per week for 8 weeks) is administered to aged C57BL/6J mice (22–24 months, both sexes) following a senolytic priming course (dasatinib + quercetin, oral, 5-day pulse, 2 weeks prior to Klotho initiation),

THEN renal tubular progenitor cells and hippocampal neural stem cells will exhibit measurably restored mitochondrial membrane potential (≥30% increase in JC-1 red:green ratio vs. aged vehicle), re-entry into regenerative cycling (≥25% increase in EdU+ Sox2+ cells in the dentate gyrus subgranular zone and ≥20% increase in LGR5+/Pax2+ renal progenitors), accompanied by a ≥15% improvement in GFR (FITC-inulin clearance), a ≥20% reduction in renal cortical collagen deposition (Masson's trichrome), and restoration of hippocampal neurogenesis (doublecortin+ cell density) to ≥60% of young reference levels,

BECAUSE the following causal chain operates:

1. α-Klotho protein declines progressively with mammalian aging, and this decline is mechanistically sufficient to impair mitochondrial integrity in tissue-resident progenitor/stem cells — as demonstrated directly in skeletal muscle satellite cells, where age-related Klotho loss caused mitochondrial membrane depolarization, elevated ROS, and failure of regenerative engraftment, a phenotype rescued by exogenous Klotho protein supplementation. (α-Klotho decline drives progenitor mitochondrial dysfunction)[https://doi.org/10.1038/s41467-018-07253-3]

2. Senescent cells accumulating in aged tissues (marked by p16INK4a expression) actively suppress residual stem and progenitor cell function through paracrine SASP signaling; critically, p16INK4a ablation in hypomorphic Klotho-deficient mice reverses aging phenotypes — demonstrating that senescent cell burden and Klotho deficiency operate in a mutually reinforcing axis that compound progenitor niche collapse. (p16INK4a ablation reverses Klotho-deficient aging)[https://doi.org/10.1038/ncomms8035] Therefore, senolytic priming (dasatinib + quercetin) first clears p16INK4a+ niche suppressors, unblocking the progenitor compartment before Klotho restoration.

3. In the aged renal environment, Klotho deficiency activates Wnt/β-catenin signaling and GSK3β-mediated pathways, driving TGF-β–mediated fibrosis and epithelial-to-mesenchymal transition of renal tubular progenitors; exogenous Klotho restoration suppresses this cascade, preserving tubular progenitor identity and preventing their conversion into pro-fibrotic myofibroblast-like cells. (Klotho deficiency activates Wnt/β-catenin and drives CKD fibrosis in aged mice)[https://doi.org/10.1101/2024.09.08.611868]

4. Circulating anti-aging proteins can reverse already-established organ-level pathology in aged mice — as demonstrated by GDF11, a parabiosis-identified circulating factor that reversed existing age-related cardiac hypertrophy through systemic administration, validating the paradigm that systemic protein replacement...

SENS category: RepleniSENS

Key references: • doi.org/10.1038/s41467-018-07253-3] • doi.org/10.1038/ncomms8035] • doi.org/10.1101/2024.09.08.611868] • doi.org/10.1016/j.cell.2013.04.015] • doi.org/10.1016/j.cell.2013.04.015